| ADR Ontology |
| ADR Term |
Lymphomatoid papulosis |
| ADR ID |
BADD_A08270 |
| ADR Hierarchy |
|
| Description |
Clinically benign, histologically malignant, recurrent cutaneous T-cell lymphoproliferative disorder characterized by an infiltration of large atypical cells surrounded by inflammatory cells. The atypical cells resemble REED-STERNBERG CELLS of HODGKIN DISEASE or the malignant cells of CUTANEOUS T-CELL LYMPHOMA. In some cases, lymphomatoid papulosis progresses to lymphomatous conditions including MYCOSIS FUNGOIDES; HODGKIN DISEASE; CUTANEOUS T-CELL LYMPHOMA; or ANAPLASTIC LARGE-CELL LYMPHOMA. [MeSH] |
| MedDRA Code |
10056670 |
| MeSH ID |
D017731
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Lymphomatoid papulosis | Lymphomatoid Papulosis | Lymphomatoid Papuloses | Papuloses, Lymphomatoid | Papulosis, Lymphomatoid |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
|
|
